Search Results 341-350 of 18691 for alzheimers
These Alzheimer's disease medicines increase levels of chemical messengers in the brain, known as neurotransmitters. These chemical messengers are believed to ...
Amyloid deposits are a hallmark sign of Alzheimer's disease. The researchers say staying mentally active doesn't stop the disease, but it may delay symptoms.
A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.
Typical Alzheimer's disease is when it starts after age 65.” Charlie Leonard. “And it would interfere with some little parts of her job, particularly toward the.
Lewy body dementia, also known as dementia with Lewy bodies, is the second most common type of progressive dementia after Alzheimer's disease dementia.
Ronald Petersen, director of the Alzheimer's Disease Research Center at Mayo Clinic, says aducanumab targets the amyloid plaques in the brain that are believed ...
The purpose of this study is to evaluate the effectiveness of LY3314814 in the treatment of people who have mild Alzheimer's disease dementia. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.